TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Investor Investigation Over Possible Securities Laws Violations

  • If you purchased shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

August 2, 2012 (Update) -- On August 1, 2012, after the market closed, Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced that the Center for Biologics Evaluation and Research (CBER) of the FDA has issued a complete response letter for Baxter's HyQ Biologics License Application. Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) dropped from $$8.61 per share on August 1, 2012, to $...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)